PT UBC Medical Indonesia Tbk (ISX:LABS) WACC %:10.46% (As of Jul. 06, 2026)


What is PT UBC Medical Indonesia Tbk WACC %?

PT UBC Medical Indonesia Tbk ISX:LABS +1.45% WACC % is 10.46% as of Jul. 06, 2026. The stock has 2 warning signs investors should review. Among 866 Medical Devices & Instruments companies, PT UBC Medical Indonesia Tbk ranks worse than 57.16% on this metric.

As of today (2026-07-06), PT UBC Medical Indonesia Tbk's weighted average cost of capital is 10.46%%. PT UBC Medical Indonesia Tbk's ROIC % is 0.00% (calculated using TTM income statement data). PT UBC Medical Indonesia Tbk earns returns that do not match up to its cost of capital. It will destroy value as it grows.

*Note: The beta of this company cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.

For a comprehensive WACC calculation, please access the WACC Calculator.

PT UBC Medical Indonesia Tbk  (ISX:LABS) WACC % Explanation

Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, PT UBC Medical Indonesia Tbk's weighted average cost of capital is 10.46%%. PT UBC Medical Indonesia Tbk's ROIC % is 0.00% (calculated using TTM income statement data). PT UBC Medical Indonesia Tbk earns returns that do not match up to its cost of capital. It will destroy value as it grows.

*Note: The beta of this company cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.

Be Aware

1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.

2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.

3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.

4. GuruFocus uses the latest annual Interest Expense divided by the latest one-year annual average debt to get the simplified cost of debt.

Related Terms

PT UBC Medical Indonesia Tbk WACC % Historical Data

* Premium members only.

The historical data trend for PT UBC Medical Indonesia Tbk's WACC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT UBC Medical Indonesia Tbk WACC % Chart

PT UBC Medical Indonesia Tbk Annual Data
Trend
WACC %

PT UBC Medical Indonesia Tbk Semi-Annual Data
WACC %

ISX:LABS vs ABT, SYK, MDT: WACC % Comparison

For the Medical Devices subindustry, PT UBC Medical Indonesia Tbk's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PT UBC Medical Indonesia Tbk WACC % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, PT UBC Medical Indonesia Tbk's WACC % distribution charts can be found below:

* The bar in red indicates where PT UBC Medical Indonesia Tbk's WACC % falls into.


PT UBC Medical Indonesia Tbk WACC % Calculation

The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.

WACC=E/(E + D)*Cost of Equity+D/(E + D)*Cost of Debt*(1 - Tax Rate)

Frequently Asked Questions Learn more about WACC % →
What does a WACC % of 10.46% mean?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a WACC % of 10.46% as of Jul. 06, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on PT UBC Medical Indonesia Tbk and its competitors. According to the industry distribution chart, PT UBC Medical Indonesia Tbk ranks #495 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 57.2%.
Is PT UBC Medical Indonesia Tbk's WACC % too high?
PT UBC Medical Indonesia Tbk's current WACC % is 10.46%. The Medical Devices & Instruments industry median WACC % is 9.10. PT UBC Medical Indonesia Tbk's value of 10.46% is 14.9% above this industry median. Based on the distribution chart, PT UBC Medical Indonesia Tbk ranks #495 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does PT UBC Medical Indonesia Tbk's WACC % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, PT UBC Medical Indonesia Tbk ranks #495 out of 866 companies for WACC %. This places PT UBC Medical Indonesia Tbk in the lower half of its industry. The industry median WACC % is 9.10. PT UBC Medical Indonesia Tbk's value of 10.46% is 14.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Medical Devices & Instruments company?
The median WACC % among Medical Devices & Instruments companies is 9.10, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT UBC Medical Indonesia Tbk's current WACC % of 10.46% is 14.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on PT UBC Medical Indonesia Tbk and its competitors. For the Medical Devices & Instruments industry, the median WACC % is 9.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT UBC Medical Indonesia Tbk's current WACC % is 10.46%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT UBC Medical Indonesia Tbk stock overvalued right now?
PT UBC Medical Indonesia Tbk (ISX:LABS) has a current WACC % of 10.46%. The current WACC % is 10.46% and 14.9% above the Medical Devices & Instruments industry median of 9.10. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For PT UBC Medical Indonesia Tbk (ISX:LABS), the current WACC % is 10.46% as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PT UBC Medical Indonesia Tbk Business Description

Address Jl. Rawagelam V, Blok L, No Kav 11-13, Kantor Pusat, Kawasan Industri Pulogadung, Kel. Jatinegara Kec. Cakung, Jakarta Timur, Jakarta, IDN
PT UBC Medical Indonesia Tbk is a distribution company. It engages in wholesale of Laboratory Equipment, Pharmaceutical Equipment, and Medical Equipment for Humans and animals, which includes the wholesale of laboratory equipment, pharmaceutical equipment, and medical equipment. It divides its main marketed medical equipment products into two categories Instruments, in the form of equipment, machines, and analyzers, are used in laboratories. The function of instruments is to process specimens or biological samples to measure and examine the levels of certain substances/contents; and Consumables include single-use medical devices used for treatment or health examinations and Reagents include chemical reagents used in laboratory tests to detect, measure, examine, & produce other substances.